Viewing Study NCT03531957


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-01-03 @ 11:30 PM
Study NCT ID: NCT03531957
Status: COMPLETED
Last Update Posted: 2023-07-03
First Post: 2018-04-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Sponsor: Asana BioSciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None eczema View